Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
Launched by UNIVERSITY OF NEBRASKA · May 8, 2023
Trial Information
Current as of April 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring different ways to collect samples for testing respiratory viruses, like the ones that cause colds or COVID-19. The current method involves using a long swab that can be uncomfortable and even painful for patients. Researchers are testing two new, less invasive methods: one that collects a wash from the back of the throat and another that gathers saliva using a special capsule. The goal is to see if these new methods are just as effective as the traditional swab but more comfortable for patients.
If you are 19 years or older and have come to the Emergency Department at Nebraska Medicine with a nasopharyngeal swab already ordered, you might be eligible to participate. In total, 1,000 participants will be asked to provide four types of samples: saliva (both by drooling and using the capsule), a wash from the throat, and a small blood sample from a finger prick. It’s important to know that you can choose not to provide any of these samples if you don’t want to. All samples collected will help researchers learn more about how to diagnose respiratory infections quickly and comfortably.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 19 years or older presenting to the UNMC ED, or admitted from the UNMC ED with a non-research nasopharyngeal swab ordered.
- Exclusion Criteria:
- • None, if the inclusion criterion is met.
Trial Officials
Thanh Nguyen, PhD
Principal Investigator
University of Nebraska
About University Of Nebraska
The University of Nebraska is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong commitment to improving patient outcomes and fostering scientific discovery, the university collaborates with various healthcare professionals and researchers to conduct rigorous clinical studies across diverse medical fields. The institution prioritizes ethical standards and patient safety while striving to translate research findings into practical solutions that enhance medical practices and contribute to the overall well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Omaha, Nebraska, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported